The preservation of living biological systems at extremely low temperatures remains one of the most significant unsolved challenges in modern science. While many individual cell types can be cryopreserved successfully, current methods remain inadequate for preserving complex tissues, organs, and whole organisms without substantial damage resulting from ice crystal formation, cellular rupture, and loss of biological function.
This proposal seeks support to investigate and validate a novel cryopreservation approach that may significantly reduce or eliminate the cellular damage associated with freezing and thawing processes. If successful, the technology could have transformative applications across medicine, organ transplantation, biotechnology, military medicine, emergency response, and long-duration space exploration.
Background
The proposed concept was derived from the study of a technique currently used for a different purpose. Preliminary analysis suggests that adapting the underlying principles of this technique may offer a new pathway toward protecting biological structures during cryogenic storage.
At this stage, the specific method remains confidential and cannot be publicly disclosed. Detailed technical information would be provided only under appropriate confidentiality agreements.
Opportunity
A successful solution to large-scale cryopreservation would address major limitations in:
- Organ transplantation and donor organ storage
- Regenerative medicine
- Biobanking and biological sample preservation
- Military and disaster medicine
- Long-duration spaceflight and planetary exploration
- Advanced biotechnology and pharmaceutical research
Request
I am seeking collaboration with a qualified research organization, biotechnology company, university laboratory, or other capable institution that can evaluate and experimentally test the proposed method.
My professional background is not in medicine or cryobiology, and I do not currently possess the laboratory resources required to validate the concept independently. Therefore, I seek a partner with the scientific expertise, facilities, and regulatory capabilities necessary to conduct rigorous testing.
Intellectual Property
The method has not yet been patented and remains confidential. Prior to disclosure, I would seek an appropriate confidentiality agreement. Depending on the outcome of validation efforts, I am open to discussing arrangements involving assignment of intellectual property rights, licensing, inventor recognition, financial compensation, or other mutually beneficial agreements.